Skip to main content

Fiscal Wizard · Single-issue tearsheet

FATE / Jun 22, 2026 Run #7707

FATE

Fate Therapeutics, Inc.

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.

Composite verdict

F 14.7 / 100
Bearish setup · Trend Following 6 drivers · 2 gates blocking
  • Coppock Curve
  • Parabolic SAR Flip
  • Accumulation/Distribution Line
Consider long put target Δ ~0.60 · ~35 DTE Bearish setup, Grade B → ITM put target

Industry rank 356th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 17 signals100% Bear
Momentum Bearish 13Mean-reversion Neutral 41

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

25.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Free Cash Flow Yield 0
P/B 75
Revenue Growth (YoY) 0
Days Sales Outstanding 0

Technicals Bearish

4.0 / 100

Bearish setup leads (Coppock Curve, Parabolic SAR Flip, Accumulation/Distribution Line); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Coppock Curve 16
Parabolic SAR Flip 20
Accumulation/Distribution Line 24

Risk Gates

2 blocking 8 caution

2 guards active, 22 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for FATE.